Free Trial
OTCMKTS:PCHM

PharmChem Q4 2024 Earnings Report

$3.75 0.00 (0.00%)
As of 06/12/2026

PharmChem EPS Results

Actual EPS
$0.06
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

PharmChem Revenue Results

Actual Revenue
$1.52 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

PharmChem Announcement Details

Quarter
Q4 2024
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

PharmChem Earnings Headlines

SpaceX is offering you shares. Don't take them.
SpaceX is reserving 30% of its IPO shares for retail investors through Robinhood, Fidelity, and Schwab. At a $1.75 trillion valuation and 266 times earnings, you're buying in at the most expensive IPO in history - right when institutions who got in at $800 billion need someone to sell to. Dylan Jovine has identified a small company in Musk's supply chain that builds the power infrastructure Colossus can't run without - and it's still trading at a fraction of its value.tc pixel
PharmChem, Inc. (PCHM) - Yahoo Finance
See More PharmChem Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like PharmChem? Sign up for Earnings360's daily newsletter to receive timely earnings updates on PharmChem and other key companies, straight to your email.

About PharmChem

PharmChem (OTCMKTS:PCHM), Inc. provides PharmChek Sweat Patch that is used to detect drugs of abuse. Its PharmChek Sweat Patch uses sweat as the source and offers alternative to urine testing for cocaine, opiates, amphetamines, PCP, and marijuana. The company was incorporated in 2000 and is based in Fort Worth, Texas.

View PharmChem Profile